A detailed history of Engineers Gate Manager LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Engineers Gate Manager LP holds 30,021 shares of ADPT stock, worth $101,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,021
Holding current value
$101,771
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.88 - $4.8 $86,460 - $144,100
30,021 New
30,021 $96,000
Q2 2023

Aug 14, 2023

SELL
$6.19 - $8.78 $68,349 - $96,948
-11,042 Reduced 34.4%
21,057 $141,000
Q1 2023

May 15, 2023

BUY
$7.8 - $10.11 $69,256 - $89,766
8,879 Added 38.24%
32,099 $283,000
Q4 2022

Feb 14, 2023

SELL
$6.26 - $9.34 $52,114 - $77,755
-8,325 Reduced 26.39%
23,220 $177,000
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $205,042 - $399,675
31,545 New
31,545 $225,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $484M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.